Anew Health Limited (AVG)

Anew Health Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2023
Revenue	41.32	40.8	27.28
Revenue Growth (YoY)	-	49.55%	-
Cost of Revenue	-	11.29	10.18
Gross Profit	29.58	29.51	17.1
Selling, General & Admin	-	14.37	10.76
Operating Expenses	-	14.37	10.76
Operating Income	12.69	15.15	6.33
Interest Expense / Income	0.91	1	1.02
Other Expense / Income	-0.02	-0.03	-0.79
Pretax Income	11.8	14.17	6.11
Income Tax	2.04	2.44	0.83
Net Income	9.76	11.73	5.28
Net Income Growth	-	122.11%	-
Free Cash Flow	1.61	4.47	6.7
Gross Margin	71.58%	72.34%	62.67%
Operating Margin	30.72%	37.12%	23.21%
Profit Margin	23.62%	28.76%	19.37%
Free Cash Flow Margin	3.89%	10.96%	24.54%
Effective Tax Rate	17.27%	17.21%	13.54%
EBITDA	15.72	18.28	9.62
EBITDA Margin	38.06%	44.81%	35.25%
Depreciation & Amortization	3.02	3.1	2.49
EBIT	12.71	15.18	7.13
EBIT Margin	30.76%	37.20%	26.12%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).